Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT03040609
Collaborator
(none)
232
1
44.8
5.2

Study Details

Study Description

Brief Summary

The main objective of this study is to develop and validate a visio-behavioral scale of visual abilities for subjects with profound multiple intellectual disabilities.

The secondary objectives of the study are:
  • to validate the structure of the scale.

  • to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.

  • to evaluate the feasibility of visio-behavioral scale.

  • to evaluate the sensitivity to change.

  • to study the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).

  • to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Visual-behavioral Scale at day 1
  • Behavioral: Test-retest at the end of 2 weeks
  • Behavioral: Test at 6 months

Detailed Description

This study includes 3 phases:
  • Elaboration of a list of behavioral items by a group of multi-disciplinary expertise (physicians, nurses, caregivers, ophthalmologies, orthoptists) based on their clinical experiences.

  • Development of the scale based on the sample obtained by a prospective multicenter research trial.

  • Validation of the sample obtained by a prospective transversal multicenter study.

This study will be performed in 5 centers in France. The enrollment of patients planned for 24 months targeting 310 patients. The duration of follow-up of the study for each patient will be varied according to the group of patients, il will be 1 day for group 1, 2 weeks for group 2, or 6 months for group 3.

Study Design

Study Type:
Observational
Actual Enrollment :
232 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Development of a Visio-behavioral Scale to Evaluate Visual Abilities of Patients With Profound Multiple Intellectual Disabilities (PLH-Vision)
Actual Study Start Date :
Jul 20, 2017
Actual Primary Completion Date :
Apr 13, 2021
Actual Study Completion Date :
Apr 13, 2021

Arms and Interventions

Arm Intervention/Treatment
Group 1

The duration of follow-up of group 1 in the study is 1 day.

Behavioral: Visual-behavioral Scale at day 1
To perform the classification with the scale by caregiver.

Behavioral: Test-retest at the end of 2 weeks
To perform the classification with the scale by orthoptist at the end of 2 weeks

Behavioral: Test at 6 months
To perform the classification with the scale by orthoptist at the end 6 months.

Group 2

The duration of follow-up of group 2 in the study is 2 weeks.

Behavioral: Test-retest at the end of 2 weeks
To perform the classification with the scale by orthoptist at the end of 2 weeks

Behavioral: Test at 6 months
To perform the classification with the scale by orthoptist at the end 6 months.

Group 3

The duration of follow-up of group 3 in the study is 6 months.

Behavioral: Test at 6 months
To perform the classification with the scale by orthoptist at the end 6 months.

Outcome Measures

Primary Outcome Measures

  1. Concordance of classification [throughout the study: 31 months]

    Statistical analysis: concordance between the classification obtained by caregiver with the scale, and the classification obtained by orthoptist-ophthalmology.

Secondary Outcome Measures

  1. Structure of the scale [throughout the study: 31 months]

    Statistical analysis to validate the structure of the scale.

  2. Reproducibility of scale [throughout the study: 31 months]

    Statistical analysis to evaluate the reproducibility of scale with the intra- and inter-examiners, and the influence of the different professions of examiners.

  3. Feasibility of visio-behavioral scale [throughout the study: 31 months]

    Statistical analysis to evaluate by the proportion of patients who have the complet examination, the average of time to all examens, the tolerance data. feasibility of visio-behavioral scale.

  4. Sensitivity to change [throughout the study: 31 months]

    Statistical analysis to evaluate the sensitivity to change.

  5. Uniformity of use of the scale [throughout the study: 31 months]

    Statistical analysis to assess the uniformity of use of the scale depending on the type of patients (age, disability level, pathology).

  6. Prevalence of the visual disorder [throughout the study: 31 months]

    Statistical analysis to study the prevalence of the visual disorder in profound multiple intellectual disabilities subjects.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Causal brain injury occurred before the age of 3 years.

  • Severe or deep mental retardation as defined by DSM IV.

  • Motor impairment: para / tetraparesis, hemiparesis, ataxia, or extrapyramidal motor disorders.

  • Score of Gross Motor Function Classification System [Palisano 1997] is III, IV or V.

  • Score of Functional Independence Measure < 55.

  • Subject aged ≥3 years (because the visio-behavioral scale is not adapted for children younger than 3 years).

  • Beneficiary of a social protection.

  • Written consent signed by guardian or legal representative, or parents in case of a minor subject.

Exclusion Criteria:
  • Acute intercurrent pathology precluding examinations.

  • Patient with hypersensitivity to tropicamide, atropine or benzalkonium chloride.

  • Angle closure glaucoma suspect patient.

  • Patient with severe hypertension.

  • Short life expectancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital San Salvadour Hyères Var France 83407

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Marie-Christine ROUSSEAU, MD, AP-HP, Hôpital San Salvadour, 83407 Hyères
  • Study Chair: Soizic CHARBONNIER, Orthoptist, Cabinet du Lycée

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT03040609
Other Study ID Numbers:
  • P140712
  • RCB: 2016-A00278-43
First Posted:
Feb 2, 2017
Last Update Posted:
Sep 23, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2021